Login / Signup

Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration.

Yimin YuJingjing HeZhiwei HuangYan LiYing WuYifeng ShenYanling ZhouCungang BaoZhiping JinHuafang Li
Published in: Expert opinion on investigational drugs (2023)
https://clinicaltrials.gov (identifier: NCT05233657).
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • endothelial cells
  • phase iii
  • phase ii
  • study protocol
  • open label
  • induced pluripotent stem cells
  • pluripotent stem cells